Charah Solutions, Inc.
CHRA
OTC PK
| Weiss Ratings | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Price History | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $51.50 | |||
| 52-Week Low Price | $1.07 | |||
| 52-Week Low Price (Date) | Apr 05, 2023 | |||
| 52-Week High Price (Date) | Aug 02, 2022 | |||
| Valuation | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 312.54M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -37.53 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.07 | |||
| Price/Book (Q) | -0.18 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.38M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 502 245 1353 | |||
| Address | 12601 Plantside Drive Louisville, KY 40299 | |||
| Website | www.charah.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -- | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | -- | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -- | |||
| Current Ratio (Q) | -- | |||
| Book Value Per Share (Q) | -$34.73 | |||
| Total Assets (Q) | 320.77M | |||
| Total Current Liabilities (Q) | -- | |||
| Total Debt (Q) | 231.14M | |||
| Total Liabilities (Q) | 365.80M | |||
| Total Common Equity (Q) | -- | |||
| Cash Flow | CHRA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
